Please login to the form below

Not currently logged in
Email:
Password:

Innovative Medicines Initiative appoints executive director

Pierre Meulien joins from Genome Canada 

edit-Innovative-Medicines-Initiative-pierre-meulienInnovative Medicines Initiative (IMI) has named Pierre Meulien as executive director, effective from September.

Meulien is currently president and CEO of Genome Canada, a not-for-profit organisation that aims to find new uses for genomics. At the organisation, he successfully secured funding from the Canadian government and leveraged further funding through partnerships.

Commenting on his appointment, Meulien said: “I am delighted to have been selected to lead the second phase of the Innovative Medicines Initiative. 

“This unique joint venture will deliver health innovations to millions of European citizens and solidify an important industry based in Europe that will be a source of jobs and growth in all of the member states.”

Prior to joining Genome Canada in 2010, Meulien served as CSO for Genome British Columbia, where he promoted the organisation's scientific strategy, and prior to that was founding CEO of the Dublin Molecular Medicine Centre.

Carlos Moedas, European commissioner for research, science and innovation, said: “The excellent results coming out of IMI's projects contribute to improving public health and are stimulating innovation and job creation in Europe. Pierre Meulien's invaluable experience will help IMI deliver on its ambitious objectives.”

22nd June 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics